Diltiazem Hydrochloride in 0.72% Sodium Chloride Injection

WG Critical Care, LLC

Revision date : 2025-03-24

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating 4
Safety risk rating 1
Environmental risk rating 1

Note: Ingredients listed on restricted chemical lists

EC/CAS

7732-18-5

Name of the chemical

Water, distilled, conductivity or of similar purity H2O

Concentration

80 - 100

EC/CAS

50-70-4

Name of the chemical

D-glucitol C6H14O6

Concentration

1-5

EC/CAS

1310-73-2

Name of the chemical

Potassium or sodium hydroxide (20)

Concentration

<0.1

EC/CAS

7647-01-0

Name of the chemical

Hydrochloric acid

Concentration

<0.1

EC/CAS

77-92-9

Name of the chemical

Citric acid

Concentration

<0.1

General Information

Version

1.0

Revision date

2025-03-24

Product name

Diltiazem Hydrochloride in 0.72% Sodium Chloride Injection

1.2.1 Relevant identified uses

Treatment of high blood pressure (hypertension), angina

1.2.2. Uses advised against

No additional information available

Emergency telephone

+1-866-562-4708

Icons in SDS

M004 M009 M010 M017

Company Information

company name

WG Critical Care, LLC

e-mail address of the competent person responsible for the Safety Data Sheet

wgccquality@wgcriticalcare.com

Hazard Codes

Hazard statements (CLP)

H362

Hazard statements

Code

Statements

H362

May cause harm to breast-fed children

Section 2

SECTION 2: Hazards identification

Classification of the Substance or Mixture GHS-US Classification Reproductive toxicity, Additional category, Effects on or via lactation H362

2.2 Label elements

GHS-US Labeling

Hazard statements

H362 - May cause harm to breast-fed children.

Precautionary statements

P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe mist, spray, vapors. P263 - Avoid contact during pregnancy and while nursing. P264 - Wash hands, forearms and face thoroughly after handling. P270 - Do not eat, drink or smoke when using this product. P308+P313 - If exposed or concerned: Get medical advice/attention. 2.3 Hazards associated with known or reasonably anticipated uses This product is a pharmaceutical product designed for administration to a patient by a qualified medical professional. No other uses are anticipated. A Process Hazard Analysis (PHA) or other hazard assessment for additional specific end uses should be performed to ensure that hazards are fully understood, and adequate safety measures are in place. See Section 10 for relevant reactivity and stability information.

2.3 Other hazards

Exposure may aggravate pre-existing eye, skin, or respiratory conditions.

Ingredient(s) with unknown acute toxicity

Dermal and Inhalative toxicity is unknown, but is not expected to be hazardous.

2.1 Classification of the substance or mixture

GHS-US Classification Reproductive toxicity, Additional category, Effects on or via lactation H362

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.